Japanese Pharmaceuticals & Biotech High Growth Potential Companies

Solasia Pharma K.K

Market Cap: JP¥7.0b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

GNI Group

Market Cap: JP¥90.7b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥17.1b

Engages in the regenerative medicine business in Japan.

CellSource

Market Cap: JP¥12.3b

Engages in the regenerative medicine-related businesses in Japan.

Daiichi Sankyo Company

Market Cap: JP¥5.8t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

RaQualia Pharma

Market Cap: JP¥7.3b

Engages in the research and development of pharmaceutical compounds worldwide.

Kidswell Bio

Market Cap: JP¥4.9b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Takara Bio

Market Cap: JP¥91.9b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Nxera Pharma

Market Cap: JP¥65.2b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Sumitomo Pharma

Market Cap: JP¥205.0b

Engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥52.5b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Astellas Pharma

Market Cap: JP¥2.3t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

JCR Pharmaceuticals

Market Cap: JP¥51.3b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

PeptiDream

Market Cap: JP¥241.5b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Daito PharmaceuticalLtd

Market Cap: JP¥32.2b

Manufactures and sells pharmaceutical products worldwide.

Zeria Pharmaceutical

Market Cap: JP¥96.3b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.